Insider trading

Period: 120 months Stock: ANNX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

96 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

96 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

96 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

96 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
96 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
96 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

96 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
15 Jul 2024
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER
Sold at will
$6.66K 1,104 at 6.03
1.3%
Not planned
15 Jul 2024
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$4.72K 784 at 6.02
0.8%
Not planned
1 Jul 2024
Bought on a plan
$16.00K 3,200 at 5.00
33.3%
Bought on a plan
3 Jun 2024
Bought on a plan
$15.46K 3,200 at 4.83
50.0%
Bought on a plan
1 May 2024
Bought on a plan
$14.98K 3,200 at 4.68
100%
Bought on a plan
8 Apr 2024
Bought on a plan
$19.41K 3,200 at 6.07
opened
Bought on a plan
20 Feb 2024
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$14.35K 2,604 at 5.51
3.5%
Not planned
20 Feb 2024
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER
Sold at will
$14.34K 2,593 at 5.53
3.1%
Not planned
20 Feb 2024
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$10.69K 1,951 at 5.48
2.2%
Not planned
12 Feb 2024
Love Douglas PRESIDENT AND CEO
Sold at will
$32.03K 5,782 at 5.54
2.9%
Not planned
12 Feb 2024
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$10.03K 1,810 at 5.54
4.8%
Not planned
12 Feb 2024
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER
Sold at will
$10.02K 1,809 at 5.54
3.8%
Not planned
12 Feb 2024
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$7.46K 1,349 at 5.53
2.7%
Not planned
27 Dec 2023
Yednock Ted EVP & Chief Innovation Officer
Sold on a plan
$94.97K 21,000 at 4.52
100%
Sold half or more
26 Dec 2023
Satter Muneer A Director · indirect
Bought
$1.01M 350,000 at 2.88
5.0%
11 Jul 2023
Lew Jennifer EVP & Chief Financial Officer
Sold at will
$4.05K 1,057 at 3.84
2.2%
Not planned
11 Jul 2023
Overdorf Michael EVP & Chief Business Officer
Sold at will
$3.75K 978 at 3.84
2.1%
Not planned
25 May 2023
Bought
$639.72K 300,000 at 2.13
5.6%
First buy on file
15 Feb 2023
Love Douglas President & CEO
Sold, plan not stated
$38.56K 6,571 at 5.87
3.2%
14 Feb 2023
Lew Jennifer EVP & Chief Financial Officer
Sold, plan not stated
$1.05K 166 at 6.30
0.6%
14 Feb 2023
Overdorf Michael EVP & Chief Business Officer
Sold, plan not stated
$907.10 144 at 6.30
0.5%
13 Feb 2023
Lew Jennifer EVP & Chief Financial Officer
Sold, plan not stated
$10.99K 1,742 at 6.31
5.5%
13 Feb 2023
Overdorf Michael EVP & Chief Business Officer
Sold, plan not stated
$9.46K 1,501 at 6.30
5.1%
10 Feb 2023
Satter Muneer A Director · indirect
Bought
$18.00M 2,647,058 at 6.80
60.0%
Largest buy in 3 yrs
7 Jul 2022
Satter Muneer A Director · indirect
Bought
$9.42M 2,453,988 at 3.84
126%
First buy on file
14 Apr 2022
Love Douglas President & CEO
Bought
$146.81K 60,000 at 2.45
42.6%
First buy on file
16 Sep 2021
Love Douglas President & CEO
Sold, plan not stated
$165.34K 7,500 at 22.05
100%
Sold half or more
13 Sep 2021
Yednock Ted EVP & Chief Scientific Officer
Sold, plan not stated
$323.86K 16,190 at 20.00
100%
Sold half or more
13 Sep 2021
Lew Jennifer EVP & Chief Financial Officer
Sold, plan not stated
$70.03K 3,500 at 20.01
63.6%
Sold half or more
8 Jun 2021
Love Douglas President & CEO
Sold, plan not stated
$84.56K 3,750 at 22.55
100%
Sold half or more
7 Jun 2021
Love Douglas President & CEO
Sold, plan not stated
$83.67K 3,750 at 22.31
100%
Sold half or more
3 Jun 2021
Yednock Ted EVP & Chief Scientific Officer
Sold, plan not stated 2×
$322.32K 15,000 at 21.49
100%
Sold half or more
27 May 2021
Lew Jennifer EVP & Chief Financial Officer
Sold, plan not stated
$77.84K 3,500 at 22.24
63.6%
Sold half or more
1 Apr 2021
Love Douglas President & CEO
Sold, plan not stated 2×
$14.04K 500 at 28.08
100%
Sold half or more
31 Mar 2021
Love Douglas President & CEO
Sold, plan not stated
$199.62K 7,102 at 28.11
100%
Sold half or more
30 Mar 2021
Love Douglas President & CEO
Sold, plan not stated 2×
$91.97K 3,750 at 24.52
100%
Sold half or more
29 Mar 2021
Love Douglas President & CEO
Sold, plan not stated 3×
$95.33K 3,750 at 25.42
100%
Sold half or more
25 Mar 2021
Yednock Ted EVP & Chief Scientific Officer
Sold, plan not stated 3×
$465.77K 16,175 at 28.80
100%
Sold half or more
24 Mar 2021
Keswani Sanjay Chandru EVP & Chief Medical Officer
Sold, plan not stated
$120.51K 3,995 at 30.17
100%
Sold half or more
23 Mar 2021
Lew Jennifer EVP & Chief Financial Officer
Sold, plan not stated 3×
$142.18K 5,000 at 28.44
71.4%
Sold half or more
28 Jul 2020
Bought
$6.80M 400,000 at 17.00
14.1%
First buy on file
28 Jul 2020
Flynn James E 10% owner · indirect
Bought
$5.95M 350,000 at 17.00
76.3%
First buy on file
28 Jul 2020
Flynn James E 10% owner · indirect
Bought
$5.95M 350,000 at 17.00
76.3%
First buy on file
28 Jul 2020
Clarus Lifesciences III, L.P. 10% owner · indirect
Bought
$3.40M 200,000 at 17.00
7.9%
First buy on file
28 Jul 2020
Satter Muneer A Director · indirect
Bought
$3.40M 200,000 at 17.00
11.4%
First buy on file
28 Jul 2020
Lew Jennifer EVP & Chief Financial Officer
Bought
$34.00K 2,000 at 17.00
opened
First buy on file
Showing 51–96 of 96. ← Newer Page 2 of 2